Quantitative assessment of the complex dynamics of G1, S, and G2-M checkpoint activities

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5234-5240

  Ubezio, Paolo ^a   Lupi, Monica ^a   Branduardi, Davide ^a   Cappella, Paolo ^a   Cavallini, Edoardo ^a   Colombo, Valentina ^a   Matera, Giada ^a   Natoli, Claudia ^a   Tomasoni, Daniela ^a   D'Incalci, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MELPHALAN; PACLITAXEL; TOPOTECAN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL FATE; CELL PROLIFERATION; COMPUTER SIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

CELL DIVISION; CELL LINE; COMPUTER SIMULATION; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; HUMANS; NEOPLASMS; S PHASE;

EID: 67449149944     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3911     Document Type: Article

References (39)

1. Montalenti F, Sena G, Cappella P, Ubezio P. Simulating cancer-cell kinetics after drug treatment: application to cisplatin on ovarian carcinoma. Phys Rev E 1998;57:5877-5887 (Pubitemid 128579511)
2. Sena G, Onado C, Cappella P, Montalenti F, Ubezio P. Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by Taxol. Cytometry 1999;37:113-124 (Pubitemid 29463480)
3. Lupi M, Matera G, Branduardi D, D'Incalci M, Ubezio P. Cytostatic and cytotoxic effects of topotecan decoded by a novel mathematical simulation approach. Cancer Res 2004;64:2825-2832 (Pubitemid 38500621)
4. Lupi M, Matera G, Natoli C, Colombo V, Ubezio P. The contribution of p53 in the dynamics of cell cycle response to DNA damage interpreted by a mathematical model. Cell Cycle 2007;6:943-950 (Pubitemid 46658749)
5. Lupi M, Cappella P, Matera G, Natoli C, Ubezio P. Interpreting cell cycle effects of drugs: the case of melphalan. Cancer Chemother Pharmacol 2006;57:443-457 (Pubitemid 43087587)
6. Ubezio P. Microcomputer experience in analysis of flow cytometric DNA distributions. Comput Programs Biomed 1985;19:159-166 (Pubitemid 15098483)
7. Spinelli L, Torricelli A, Ubezio P, Basse B. Modelling the balance between quiescence and cell death in normal and tumour cell populations. Math Biosci 2006;202:349-370 (Pubitemid 44188803)
8. Basse B, Ubezio P. A generalised age- and phase-structured model of human tumour cell populations both unperturbed and exposed to a range of cancer therapies. Bull Math Biol 2007;69:1673-1690 (Pubitemid 46957466)
9. Webb G. Theory of nonlinear age-dependent population dynamics. New York: Marcel Dekker; 1985.
10. Arino O. A survey of structured cell population dynamics. Acta Biotheor 1995;43:3-25.
11. Bertuzzi A, Gandolfi A, Sinisgalli C, Iacoviello D. Steel's potential doubling time and its estimation in cell populations affected by nonuniform cell loss. Math Biosci 1997;143:61-89. (Pubitemid 27414816)
12. White RA. Computing multiple cell kinetic properties from a single time point. J Theor Biol 1989;141:429-446 (Pubitemid 20023103)
13. Komarova NL, Wodarz D. Drug resistance in cancer: principles of emergence and prevention. Proc Natl Acad Sci U S A 2005;102:9714-9719 (Pubitemid 40981746)
14. Gardner SN. Cell cycle phase-specific chemotherapy: computational methods for guiding treatment. Cell Cycle 2002;1:369-374
15. Skipper HE, Schabel FM Jr, Wilcox WS. Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic concepts underlying chemotherapy of leukemia. Cancer Chemother Rep 1965;45:5-28.
16. Takahashi M. Theoretical basis for cell cycle analysis: II. Further studies on labelled mitosis wave method. J Theor Biol 1968;18:195-209.
17. Gray JW. Cell-cycle analysis of perturbed cell populations: computer simulation of sequential DNA distributions. Cell Tissue Kinet 1976;9:499-516.
18. Kozusko F, Chen P, Grant SG, Day BW, Panetta JC. A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A. Math Biosci 2001;170:1-16. (Pubitemid 32230645)
19. Basse B, Baguley BC, Marshall ES, et al. Modelling cell death in human tumour cell lines exposed to the anticancer drug paclitaxel. J Math Biol 2004;49:329-357 (Pubitemid 40171917)
20. Dionysiou DD, Stamatakos GS, Uzunoglu NK, Nikita KS, Marioli A. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J Theor Biol 2004;230:1-20. (Pubitemid 38951124)
21. Hinow P, Wang SE, Arteaga CL, Webb GF. A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor. Theor Biol Med Model 2007;4:14.
22. Pallavicini MG, Gray JW, Folstad LJ. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-β-D- arabinofuranosylcytosine. Cancer Res 1982;42:3125-3131 (Pubitemid 12041067)
23. Panetta JC, Evans WE, Cheok MH. Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells. Br J Cancer 2006;94:93-100. (Pubitemid 43088547)
24. Simeoni M, Magni P, Cammia C, et al. Predictive pharmacokinetic- pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res 2004;64:1094-1101 (Pubitemid 38176915)
25. Dethlefsen LA, editor. Cell cycle effects of drugs. Oxford: Pergamon Press; 1986.
26. 2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes. J Exp Clin Cancer Res 2000;19:483-488
27. Potter AJ, Gollahon KA, Palanca BJ, et al. Flow cytometric analysis of the cell cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicin. Carcinogenesis 2002;23:389-401. (Pubitemid 34257618)
28. Attardi LD, de Vries A, Jacks T. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 2004;23:973-980 (Pubitemid 38250943)
29. 1 arrest in human cancer cells. Cancer Res 1995;55:5187-5190
30. Kim SH, Kim JH. Lethal effect of Adriamycin on the division cycle of HeLa cells. Cancer Res 1972;32:323-325
31. Kimler BF, Cheng CC. Comparison of the effects of dihydroxyanthraquinone and Adriamycin on the survival of cultured Chinese hamster cells. Cancer Res 1982;42:3631-3636 (Pubitemid 12054471)
32. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621-681 (Pubitemid 44403686)
33. Toettcher JE, Loewer A, Ostheimer GJ, Yaffe MB, Tidor B, Lahav G. Distinct mechanisms act in concert to mediate cell cycle arrest. Proc Natl Acad Sci U S A 2009;106:785-790
34. Ubezio P, Tagliabue G, Schechter B, Agur Z. Increasing 1-β-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics. Cancer Res 1994;54:6446-6451
35. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006;6:583-592 (Pubitemid 44140857)
36. Feeney GP, Errington RJ, Wiltshire M, Marquez N, Chappell SC, Smith PJ. Tracking the cell cycle origins for escape from topotecan action by breast cancer cells. Br J Cancer 2003;88:1310-1317 (Pubitemid 36606351)
37. Sigal A, Milo R, Cohen A, et al. Variability and memory of protein levels in human cells. Nature 2006;444:643-646 (Pubitemid 44864444)
38. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008;14:111-122
39. Cohen AA, Geva-Zatorsky N, Eden E, et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 2008;322:1511-1516